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TO THE EDITOR
We take the opportunity to comment on
the article by Nagy et al. (2007), which
recently appeared in your journal. Nagy
et al. (2007) presented data from a
genetic study similar to one we published
earlier in this journal (Wallace et al.,
2006), comparing the frequency of a
tumor necrosis factor (TNF)-a polymorph-
ism (TNFA-308A) in individuals with
venous leg ulcers and healthy indivi-
duals. Although our original study found
that carriage of the TNFA-308A allele
was a significant risk factor for the
development of venous leg ulcers, with
a frequency nearly twice as high in the
ulcer group, the study by Nagy et al.
(2007) found a smaller increase that was
not significant (Table 1). Instead, Nagy
et al. (2007) found that carriage of the
TNFA-308A allele was a significant risk
factor for obesity, and they suggested that
the association between the TNFA-308A
allele and venous leg ulceration is due to
‘‘the suspected high rate of obese in-
dividuals in the Australian leg-ulcer
patients’ group’’.
We have re-examined our data to
seek explanations for the difference in
results between the studies. Our com-
ments relate to the genetics of the major
histocompatibility complex (MHC), to
possible differences in the case and
control sample populations between
the two studies, to the statistical analy-
sis, and to the rate of overweight
individuals in our leg-ulcer group.
Our study concluded that it was not
possible to determine if the increased risk
was because of the TNFA-308A allele or
other polymorphism/s in linkage disequi-
librium with this allele. The TNFA gene is
located in the central MHC, a region of
high linkage disequilibrium, and the
TNFA-308A polymorphism is commonly
part of the MHC 8.1 ancestral haplotype.
This haplotype (HLA-A1, B8, DR3, and
DQ2) is associated with numerous
immunopathological disorders and is
common in populations of Northern
European origin (Price et al., 1999). Our
study was performed in Australian Cau-
casian subjects while the Nagy et al.
(2007) study was conducted in Hungary,
where 94.4% of individuals are ethnic
Hungarians (Census 2001, http://www.
nepszamlalas.hu). In Caucasian popula-
tions, approximately 70% of individuals
carrying the TNFA-308A allele also have
part or all of the MHC 8.1 ancestral
haplotype (Price et al., 1999), but there is
variation in MHC haplotypes between
European populations (Uyar et al., 2004).
We used a surrogate marker of the
MHC 8.1 ancestral haplotype (C inser-
tion in intron 10 of the BAT1 gene) to
examine the relationship between the
TNFA-308A allele and the MHC 8.1
ancestral haplotype and to determine
the frequency of the MHC 8.1 ancestral
haplotype in our sample populations. As
Nagy et al. (2007) did not analyze this
marker or perform HLA typing, it is not
possible to confirm whether the Austra-
lian and Hungarian populations have
similar HLA haplotypes. The frequency
of TNFA-308A in the two control groups
was comparable and suggests that the
ancestry may be similar, but confirmation
at the HLA level is important because the
TNFA-308A allele may be contained in
other haplotypes that are not associated
with increased risk of venous leg
ulceration.
There are specific differences in the
study design that may also explain the
lack of concordance between the re-
sults. The sample size of the Nagy et al.
(2007) study was smaller, particularly
the control group, and therefore has less
power to demonstrate a positive asso-
ciation (Wallace et al.: 181 cases and
181 controls; Nagy et al.: 151 cases and
131 controls). However, the most im-
portant differences relate to the selec-
tion criteria for the venous leg ulcer and
healthy control subjects. The groups in
our study were matched for age but this
is not specified in the Nagy et al. (2007)
study. Our study excluded individuals
with diabetes and rheumatoid arthritis
from both the leg ulcer group and the
control group because of the associa-
tion of the TNFA-308A allele and the
MHC 8.1 ancestral haplotype with these
disorders. In the Nagy et al. (2007)
study, such individuals were excluded
from the leg ulcer group, but there is no
mention of exclusions from the control
group. The inclusion of individuals
with diabetes or rheumatoid arthritis in
the control group has the potential to
increase the frequency of the TNFA-
308A allele. Similarly, our study ex-
cluded individuals with chronic venous
insufficiency from our healthy control
group, with all control subjects having a
venous refilling time greater than 25 sec-
onds by photoplethysmography. Lastly,
while exclusion criteria are listed for the
venous leg ulcer group in Nagy et al.
(2007), no information is provided on
the inclusion criteria used to establish a
diagnosis of venous ulceration. This
lack of information makes it difficult to
make a direct comparison between the
two studies.
In Table 1 of their article, Nagy et al.
(2007) have used the Fisher’s Exact
Probability Test to compare a number
of subgroups individually with the
nonobese healthy control group. Fish-
er’s Exact Test is normally applied to
22 tables where the expected fre-
quency is low (less than five in any of
Abbreviations: BMI, body mass index; HLA, human leukocyte antigen; MHC, major histocompatibility
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the cells) (Daly and Bourke, 2000).
Given that the observed numbers are
considerably higher than this, the use of
Pearson’s w2 test would be appropriate.
The significance values reported for the
Fisher’s Exact Test are exaggerated. The
figures quoted are the probabilities for
the exact results observed in the data.
To calculate a P value for Fisher’s Exact
Test (one-sided) it is necessary to add
up the probabilities of the observed
table and the probabilities of any even
more unlikely results in the tail of the
distribution of all possible tables (Daly
and Bourke, 2000). Indeed, of all the P
values listed in Table 1 of the Nagy
et al. (2007) article, the only one that
reaches the customary level of signifi-
cance (P¼ 0.05) with the correct use of
Fisher’s Exact Test is that for the
comparison between the obese leg-
ulcer patients and the nonobese healthy
controls (P¼0.051, not P¼0.0273
(Nagy et al. 2007)). Using Pearson’s w2
test, arguably the more appropriate test,
the difference does not reach this level
of significance (P¼0.066). Similarly,
the difference in the frequency of the A
allele between the obese and nonobese
individuals of the control group does
not reach the P¼ 0.05 level of signifi-
cance using a one-sided Fisher’s Exact
Test (P¼0.090, not P¼0.0457 (Nagy
et al., 2007)) or the Pearson’s w2 test
(P¼0.124). Therefore, this data does
not strongly support the link between
the A allele and obesity.
The possible link with obesity de-
scribed in the Nagy et al. (2007) study is
still worth consideration. Although we
did not collect body mass index (BMI)
data as part of our study, our ulcer
clinic database provides BMI data for
two-thirds of the ulcer patients included
in the Wallace et al. (2006) paper. From
this data, 91% and 72% of male and
female ulcer patients, respectively, had
a BMI ofX25.0 kg/m2. Although we do
not have BMI data for our control
subjects, a recent Australian study
provides good quality data on the
national proportion of overweight and
obese individuals according to age
group and sex (Cameron et al., 2003).
The frequency of individuals with a BMI
of X25.0 kg/m2 in Australian popula-
tion controls, 65–74 years of age, is
74% for males and 67% for females.
Therefore, we estimate that our ulcer
group contained 17% more men and
5% more women with raised BMI
compared to age-matched controls.
Although this suggests the possibility
that the higher frequency of overweight
patients may partly explain the higher
frequency of the A allele, we feel this is
unlikely since the higher frequency of
overweight males compared to females
in the ulcer group is not reflected in a
higher frequency of the A allele in
males compared to females. In our
ulcer group, the frequency of the A
allele was 24.1% in males and 22.7%
in females and in controls it was 13.4
and 10.8%, respectively. In addition,
the relative increase in the frequency of
the A allele in the ulcer group com-
pared to controls is far greater than the
increased frequency of individuals with
a BMI X25.0 kg/m2.
We conclude that the paper of Nagy
et al. (2007) and further evaluation of our
own data does not support the assertion
that the TNFA-308A allele is primarily
associated with obesity and not with
venous ulceration. Multicenter interna-
tional studies that harmonize patient
inclusion and exclusion criteria and test
the same range of genetic markers would
assist in clarifying the relationship be-
tween venous ulceration, obesity, the
TNFA-308A allele, and MHC haplotypes.
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Table 1. Frequency of the TNFA-308A allele in studies by Wallace et al.
(2006) and Nagy et al. (2007)
Frequency of the TNFA-308A allele
Odds ratio1
(95% CI) Significance
(Pearson’s v2)
Venous leg ulcer
patients Healthy controls
Wallace et al. (2006)
(Australia)
0.234 0.116 2.34 (1.56–3.50)
P=0.00003
Nagy et al. (2007) (Hungary) 0.182 0.153 1.24 (0.79–1.93) P=0.35
CI, confidence interval; TNFA, tumour necrosis factor-a (gene).
1In Wallace et al. (2006) the odds ratio was calculated using carrier frequency data (frequency of
homozygotes+heterozygotes), but to enable a direct comparison between the studies the odds ratio
presented here uses allele frequency data.
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